An evaluation of secukinumab for the treatment of moderate-to-severe hidradenitis suppurativa
{{output}}
Introduction: Until recently, biological therapy for hidradenitis suppurativa was limited to anti-tumor necrosis factor (TNF) blockade with adalimumab (ADA). However, not all patients respond to treatment with ADA. This highlight... ...
